Over the past 16 years, GPs have got much better at diagnosing and treating people with atrial fibrillation. And it’s saving lives.
Robust comparisons of Pradaxa and warfarin based on systematically collected data haven’t revealed a significant difference in safety of the two therapies.
ec-jpr/Flickr
Pharmaceutical companies don’t have a particularly good reputation, for some very good reasons. But we can’t let suspicions about the motives of such companies cloud our assessments of drug safety because…
Professor of Bioethics & Medicine, Sydney Health Ethics, Haematologist/BMT Physician, Royal North Shore Hospital and Director, Praxis Australia, University of Sydney